Nuvectis Pharma, Inc. (NVCT) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 84.27 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
NVCT overview · NVCT earnings · NVCT KPIs · NVCT documents · NVCT ownership · NVCT peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.